Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

HSP90 inhibitors: current development and potential in cancer therapy.

Sidera K, Patsavoudi E.

Recent Pat Anticancer Drug Discov. 2014 Jan;9(1):1-20. Review.

PMID:
23312026
[PubMed - indexed for MEDLINE]
2.

Cell surface Cdc37 participates in extracellular HSP90 mediated cancer cell invasion.

El Hamidieh A, Grammatikakis N, Patsavoudi E.

PLoS One. 2012;7(8):e42722. doi: 10.1371/journal.pone.0042722. Epub 2012 Aug 17.

PMID:
22912728
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Inhibiting matrix metalloproteinases, an old story with new potentials for cancer treatment.

Stellas D, Patsavoudi E.

Anticancer Agents Med Chem. 2012 Sep;12(7):707-17. Review.

PMID:
22292747
[PubMed - indexed for MEDLINE]
4.

The 4C5 cell-impermeable anti-HSP90 antibody with anti-cancer activity, is composed of a single light chain dimer.

Sidera K, El Hamidieh A, Mamalaki A, Patsavoudi E.

PLoS One. 2011;6(9):e23906. doi: 10.1371/journal.pone.0023906. Epub 2011 Sep 1.

PMID:
21912649
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits.

Stellas D, El Hamidieh A, Patsavoudi E.

BMC Cell Biol. 2010 Jul 5;11:51. doi: 10.1186/1471-2121-11-51.

PMID:
20602761
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Functional implications of HNK-1 expression on invasive behaviour of melanoma cells.

Casado JG, Delgado E, Patsavoudi E, DurĂ¡n E, Sanchez-Correa B, Morgado S, Solana R, Tarazona R.

Tumour Biol. 2008;29(5):304-10. doi: 10.1159/000156707. Epub 2008 Sep 19.

PMID:
18802400
[PubMed - indexed for MEDLINE]
7.

Extracellular HSP90: conquering the cell surface.

Sidera K, Patsavoudi E.

Cell Cycle. 2008 Jun 1;7(11):1564-8. Epub 2008 Apr 2.

PMID:
18469526
[PubMed - indexed for MEDLINE]
Free Article
8.

A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2.

Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E.

J Biol Chem. 2008 Jan 25;283(4):2031-41. Epub 2007 Dec 5.

PMID:
18056992
[PubMed - indexed for MEDLINE]
Free Article
9.

Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis.

Stellas D, Karameris A, Patsavoudi E.

Clin Cancer Res. 2007 Mar 15;13(6):1831-8.

PMID:
17363539
[PubMed - indexed for MEDLINE]
Free Article
10.

Upgrading the biomedical engineering undergraduate curriculum based on current trends in higher education.

Kontodimopoulos N, Cavouras D, Kandarakis I, Spyropoulos B, Patsavoudi E, Ventouras E.

Conf Proc IEEE Eng Med Biol Soc. 2004;7:5184-7.

PMID:
17271500
[PubMed]
11.

BM88 is an early marker of proliferating precursor cells that will differentiate into the neuronal lineage.

Koutmani Y, Hurel C, Patsavoudi E, Hack M, Gotz M, Thomaidou D, Matsas R.

Eur J Neurosci. 2004 Nov;20(10):2509-23.

PMID:
15548196
[PubMed - indexed for MEDLINE]
12.

Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system.

Sidera K, Samiotaki M, Yfanti E, Panayotou G, Patsavoudi E.

J Biol Chem. 2004 Oct 29;279(44):45379-88. Epub 2004 Aug 9.

PMID:
15302889
[PubMed - indexed for MEDLINE]
Free Article
13.

The 4C5 antigen is associated with Schwann cell migration during development and regeneration of the rat peripheral nervous system.

Yfanti E, Sidera K, Margaritis LH, Patsavoudi E.

Glia. 2004 Jan 1;45(1):39-53.

PMID:
14648544
[PubMed - indexed for MEDLINE]
14.

Migration behavior of rodent granule neurons in the presence of antibody to the 4C5 antigen.

Yfanti E, Nagata I, Patsavoudi E.

J Neurochem. 1998 Oct;71(4):1381-9.

PMID:
9751168
[PubMed - indexed for MEDLINE]
15.

Expression of the 4C5 antigen during development and after injury of the rat sciatic nerve.

Thomaidou D, Yfanti E, Patsavoudi E.

J Neurosci Res. 1996 Oct 1;46(1):24-33.

PMID:
8892102
[PubMed - indexed for MEDLINE]
16.

The BM88 antigen, a novel neuron-specific molecule, enhances the differentiation of mouse neuroblastoma cells.

Mamalaki A, Boutou E, Hurel C, Patsavoudi E, Tzartos S, Matsas R.

J Biol Chem. 1995 Jun 9;270(23):14201-8.

PMID:
7775480
[PubMed - indexed for MEDLINE]
Free Article
17.

Developmental expression and functional characterization of the 4C5 antigen in the postnatal cerebellar cortex.

Thomaidou D, Dori I, Patsavoudi E.

J Neurochem. 1995 May;64(5):1937-44.

PMID:
7722481
[PubMed - indexed for MEDLINE]
18.

Characterization and localization of the BM88 antigen in the developing and adult rat brain.

Patsavoudi E, Merkouri E, Thomaidou D, Sandillon F, Alonso G, Matsas R.

J Neurosci Res. 1995 Mar 1;40(4):506-18.

PMID:
7616611
[PubMed - indexed for MEDLINE]
19.

Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes.

Probert L, Keffer J, Corbella P, Cazlaris H, Patsavoudi E, Stephens S, Kaslaris E, Kioussis D, Kollias G.

J Immunol. 1993 Aug 15;151(4):1894-906.

PMID:
8345187
[PubMed - indexed for MEDLINE]
20.

Identification of a novel neuron-specific surface antigen in the developing nervous system, by monoclonal antibody 4C5.

Thomaidou D, Patsavoudi E.

Neuroscience. 1993 Apr;53(3):813-27.

PMID:
8487957
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk